Molecule2Market appoints CEO
Molecule2Market is pleased to announce the appointment of Dr Julie Ince-Demetriou as Chief Executive Officer, effective immediately.
The establishment of the Chief Executive Officer role reflects the organisation’s continued growth and the increasing scale and complexity of its operations. The role provides dedicated leadership across Molecule2Market’s strategic direction, operational management, growth initiatives, and external partnerships, supporting the organisation’s long-term development.
Dr Ince-Demetriou brings extensive clinical research experience, strong strategic leadership capability, and a proven ability to translate strategy into effective execution. She has a demonstrated track record in building and leading high-performing teams, scaling organisations in a sustainable manner, and developing collaborative partnerships across the life sciences sector.
Directors Anne De Luca and Robin Hansen will remain actively engaged in the governance, strategic oversight, and long-term vision of the organisation, and will continue to work closely with Dr Ince-Demetriou as Molecule2Market enters its next phase.
Robin Hansen commented:
“The appointment of a Chief Executive Officer represents a natural evolution for Molecule2Market. It strengthens our leadership structure while ensuring the values, vision, and intent that have guided the organisation since its inception remain firmly embedded.”
Anne De Luca added:
“Dr Ince-Demetriou brings a rare combination of commercial insight and people-centred leadership. As the organisation continues to grow, preserving our culture remains a priority, and Julie’s values align strongly with those of Molecule2Market.”
Dr Ince-Demetriou said:
“I am pleased to assume the role of Chief Executive Officer at a pivotal stage in Molecule2Market’s development. The organisation has established a strong reputation for scientific excellence and integrity, and I look forward to working with the Board, team, and clients to deliver the next phase of growth and impact.”
For more information about Molecule2Market and its global impact, follow us on LinkedIn:
